Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - UNITED THERAPEUTICS Corp | a11-8826_1ex32d1.htm |
EX-31.2 - EX-31.2 - UNITED THERAPEUTICS Corp | a11-8826_1ex31d2.htm |
EX-31.1 - EX-31.1 - UNITED THERAPEUTICS Corp | a11-8826_1ex31d1.htm |
EX-32.2 - EX-32.2 - UNITED THERAPEUTICS Corp | a11-8826_1ex32d2.htm |
EXCEL - IDEA: XBRL DOCUMENT - UNITED THERAPEUTICS Corp | Financial_Report.xls |
10-Q - 10-Q - UNITED THERAPEUTICS Corp | a11-8826_110q.htm |
Exhibit 12.1
United Therapeutics Corporation
Ratio of Earnings to Fixed Charges
(Unaudited)
|
|
Three Months |
|
Year Ended December 31, |
| ||||||||||||||
|
|
31, 2011 |
|
2010 |
|
2009 |
|
2008 |
|
2007 |
|
2006 |
| ||||||
|
|
|
|
$ in thousands |
| ||||||||||||||
Earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Earnings (lossses) from continuing operations before income taxes |
|
$ |
26,826 |
|
$ |
147,839 |
|
$ |
18,767 |
|
$ |
(83,721 |
) |
$ |
4,477 |
|
$ |
37,973 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Loss from equtiy investee |
|
37 |
|
160 |
|
141 |
|
226 |
|
321 |
|
491 |
| ||||||
Fixed charges |
|
5,495 |
|
20,089 |
|
18,326 |
|
17,357 |
|
16,855 |
|
3,589 |
| ||||||
Less: capitalized interest |
|
(82 |
) |
(103 |
) |
(5,154 |
) |
(4,757 |
) |
(689 |
) |
|
| ||||||
Earnings (losses), as adjusted |
|
$ |
32,276 |
|
$ |
167,985 |
|
$ |
32,080 |
|
$ |
(70,895 |
) |
$ |
20,964 |
|
$ |
42,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Interest expense(1) |
|
$ |
5,413 |
|
$ |
19,714 |
|
$ |
12,875 |
|
$ |
11,439 |
|
$ |
14,281 |
|
$ |
2,417 |
|
Capitalized interest |
|
82 |
|
103 |
|
5,154 |
|
4,757 |
|
689 |
|
|
| ||||||
Portion of rentals representative of interest factor |
|
|
|
272 |
|
297 |
|
1,161 |
|
1,885 |
|
1,172 |
| ||||||
Fixed charges |
|
$ |
5,495 |
|
$ |
20,089 |
|
$ |
18,326 |
|
$ |
17,357 |
|
$ |
16,855 |
|
$ |
3,589 |
|
Ratio of earnings to fixed charges |
|
5.87 |
|
8.36 |
|
1.75 |
|
(4.08 |
) |
1.24 |
|
11.72 |
| ||||||
Excess of fixed charges over earnings |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
88,252 |
|
$ |
|
|
$ |
|
|
(1) Includes amortization of debt discount and issue costs
NOTE: The ratio of earnings to fixed charges should be read in conjunction with the Consolidated Financial Statements and related Notes to the Consolidated Financial Statements and Managements Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2010, and this Quarterly Report on Form 10-Q for the three months ended March 31, 2011.